Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to ph...

Cencora, Inc. (COR) has a valuation score of 75/100 (strong), profitability score of 43/100 (weak), financial health score of 61/100 (moderate), Piotroski F-Score of 7/9, Altman Z-Score of 2.67 (grey zone), revenue growth of +10.4% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations20 analysts · 2026-08-01
5
10
5
Strong Buy 5Buy 10Hold 5Sell 0Strong Sell 0

Recent Market Moves

See all COR moves →
DateSessionPriceMoveZ-Score
Aug 12Pre-market$320.05-4.14%-2.76
Aug 6Pre-market$317.22+3.76%2.51
Aug 5Regular$317.41+3.63%2.42
Aug 5After-hours$317.79+3.76%2.51
Cencora, Inc. (COR) Valuation & P/E History →Cencora, Inc. (COR) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →